Chronic Obstructive Pulmonary Disorder
Feb 06, 2017
Chronic Obstructive Pulmonary Disorder
Downloads
Article in PDF
Recent Articles
- ATS 2023 Updates: Dupixent – A Ray of Hope For Moderate To Severe Chronic Obstructive Pulmo...
- Bristol Myers’ Opdivo combo Opdualag for Melanoma; Biogen’s Aduhelm; Marinus’ Ztalmy for CDKL-5 D...
- Assessing the Growing Role & the Demand of Apps in Managing the Chronic Diseases
- Clinical
- Ipsen’s Cabometyx Rejected by NICE; Vertex and CRISPR Therapeutics’s Submit BLA to the FDA for ex...
Downloads
Article in PDF
Recent Articles
- Biogen’s SPINRAZA Phase II/III Trial Results; Travere’s FILSPARI FDA Approval; GSK’s ...
- Airway Management Devices: Charting the Evolving Market Trends and Key Innovations
- Ipsen’s Cabometyx Rejected by NICE; Vertex and CRISPR Therapeutics’s Submit BLA to the FDA for ex...
- Lilly’s Morphic Acquisition; IDEAYA’s IDE397 Positive Phase II Trial Result; XPOVIO (seline...
- Lack of effective therapy: A major Nontuberculous Mycobacteria Infection Market Driver
